Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immatics NV
(NQ:
IMTX
)
11.79
+0.28 (+2.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Immatics NV
< Previous
1
2
Next >
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
May 24, 2024
Via
Benzinga
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Why Immatics Shares Are Rising Today
July 24, 2023
Immatics N.V. (NASDAQ: IMTX) shares are trading higher after the company announced
Via
Benzinga
Recap: Immatics Q1 Earnings
May 16, 2023
Via
Benzinga
Why Immatics Stock Is Soaring Today
May 02, 2023
Investors liked what they heard in Immatics' interim results for experimental immunotherapy IMA203.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
June 22, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 02, 2023
Via
Benzinga
What's Going On With Immatics Shares Today
May 02, 2023
Immatics N.V. (NASDAQ: IMTX) shares are shooting higher today after it revealed an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine...
Via
Benzinga
US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns
May 02, 2023
U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to...
Via
Benzinga
Immatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancers
October 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 02, 2023
Via
Benzinga
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
May 01, 2023
Bristol-Myers Squibb Co (NYSE: BMY) announced
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
March 21, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via
Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
October 11, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...
Via
Benzinga
Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday
October 10, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session.
Via
Benzinga
Why Is Nutex Health (NUTX) Stock on the Move Today?
October 10, 2022
Nutex Health (NUTX) stock is moving on Monday after the healthcare management company released a corporate update to investors.
Via
InvestorPlace
Ford Stock Slumps 7% on Analyst Downgrade
October 10, 2022
Ford (F) stock is losing traction on Monday after UBS analyst Patrick Hummel hit the automobile company's shares with a downgrade.
Via
InvestorPlace
Why Is Immatics (IMTX) Stock Up 7% Today?
October 10, 2022
Immatics (IMTX) stock is climbing higher on Monday after the biopharmaceutical company revealed an underwritten public offering.
Via
InvestorPlace
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via
Benzinga
Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket
August 10, 2022
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.